FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Immune Design news from FierceBiotech

News

Emerging Drug Developer: Immune Design


Immune Design starts recruiting for new research Up until a few years ago, vaccine development was in a torpor. Margins were slim, the manufacturing process difficult and the upside often hard to Read more...

Seattle vaccine developer raises $18M in Series A

Seattle-based Immune Design has raised an impressive $18 million in its first round of venture capital. The vaccine company is developing therapies targeting dendritic cells, which control the human Read more...